TABLE 31Immediate and ongoing (lifetime) post-stroke care costs per 3-month cycle

Post-stroke stateImmediate (first 3 months) post-stroke care costs (£)Ongoing post-stroke care costs (£)Disutility
Mild37373270.03
Moderate816116490.08a
Severe18,41766180.13
a

The disutility value for a moderate stroke was assumed to be the midpoint between the disutility values for a mild and severe stroke.

From: 5, Assessment of cost-effectiveness

Cover of The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 16.43.
Cherry MG, Greenhalgh J, Osipenko L, et al.
Southampton (UK): NIHR Journals Library; 2012 Nov.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.